Follow us on Steam Follow us on FB Follow us on Twitter Subscribe on Youtube

Global Horizontal Ad1

Collapse

Google Tag Manager

Collapse

Google Website Review Code

Collapse

Announcement

Collapse
No announcement yet.

US becomes first country in the world to approve breakthrough Alzheimer's drug lecanemab that slows symptoms by 27% and costs $27,000 a year.

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    US becomes first country in the world to approve breakthrough Alzheimer's drug lecanemab that slows symptoms by 27% and costs $27,000 a year.

    That's great news. Now, if they could only find a cure for cancer. Or diabetes.
    US first country in the world to approve lecanemab
    https://www.dailymail.co.uk
    The FDA has greenlit the drug developed by the Tokyo, Japan, company Eisai in partnership with America's Biogen. It slowed Alzheimer's by around 27 percent over 18 months.
    Tags: lecanemab
Previous template Next

Global Horizontal Ad2

Collapse
Working...
X

We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.

By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.

I Agree